In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells
British Journal of Cancer, Published online: 14 October 2019; doi:10.1038/s41416-019-0600-9In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Tetsuo Mashima Risa Iwasaki Naomi Kawata Ryuhei Kawakami Koshi Kumagai Toshiro Migita Takeshi Sano Kensei Yamaguchi Hiroyuki Seimiya Source Type: research
More News: Cancer | Cancer & Oncology | Chemistry | Gastric (Stomach) Cancer | Gastroenterology | UK Health